Stocktoria
Quoin Pharmaceuticals, Ltd. QNRX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1989-11-01
Quoin Pharmaceuticals, Ltd. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 |
| R&D expense | $9.8M | $3.6M | $3.3M | $2.7M | $1.6M | $244,155 |
| SG&A expense | $6.5M | $5.9M | $6.1M | $6.6M | $4.5M | $1.4M |
| Interest expense | — | — | — | — | $1.1M | $47,021 |
| Net income | -$15.8M | -$9.0M | -$8.7M | -$9.4M | -$21.5M | -$2.1M |
| EPS (diluted) | — | — | — | — | $-0.01 | $-0.70 |
| Operating cash flow | -$13.5M | -$7.9M | -$7.9M | -$8.5M | -$5.7M | -$1.3M |
| Cash & equivalents | $3.8M | $3.6M | $2.4M | $2.9M | $7.5M | $323,832 |
| Total assets | $20.4M | $15.7M | $12.2M | $14.5M | $9.4M | $1.4M |
| Total liabilities | $7.3M | $6.5M | $6.5M | $7.1M | $8.7M | $8.0M |
| Shareholders' equity | $13.1M | $9.2M | $5.7M | $7.4M | $657,032 | -$6.6M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.